Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Cash from Financing Activities (2019 - 2025)

Harmony Biosciences Holdings' Cash from Financing Activities history spans 7 years, with the latest figure at -$3.0 million for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities fell 10.0% to -$3.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$9.0 million, a 17.71% increase, with the full-year FY2025 number at -$9.0 million, up 17.71% from a year prior.
  • Cash from Financing Activities hit -$3.0 million in Q4 2025 for Harmony Biosciences Holdings, down from -$3.0 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for HRMY hit a ceiling of $7.1 million in Q4 2021 and a floor of -$55.1 million in Q3 2023.
  • Historically, Cash from Financing Activities has averaged -$5.6 million across 5 years, with a median of -$345500.0 in 2023.
  • Biggest five-year swings in Cash from Financing Activities: skyrocketed 11425.0% in 2022 and later plummeted 2787.76% in 2023.
  • Tracing HRMY's Cash from Financing Activities over 5 years: stood at $7.1 million in 2021, then plummeted by 62.42% to $2.7 million in 2022, then plummeted by 2113.66% to -$53.5 million in 2023, then skyrocketed by 94.88% to -$2.7 million in 2024, then decreased by 10.0% to -$3.0 million in 2025.
  • Business Quant data shows Cash from Financing Activities for HRMY at -$3.0 million in Q4 2025, -$3.0 million in Q3 2025, and -$2.7 million in Q2 2025.